High Prevalence of Anti–Severe Acute Respiratory Syndrome Coronavirus 2 (Anti–SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey

BACKGROUND: In October 2020, after the first wave of coronavirus disease 2019 (COVID-19), only 8290 confirmed cases were reported in Kinshasa, Democratic Republic of the Congo, but the real prevalence remains unknown. To guide public health policies, we aimed to describe the prevalence of severe acu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nkuba, Antoine N, Makiala, Sheila M, Guichet, Emilande, Tshiminyi, Paul M, Bazitama, Yannick M, Yambayamba, Marc K, Kazenza, Benito M, Kabeya, Trésor M, Matungulu, Elysee B, Baketana, Lionel K, Mitongo, Naomi M, Thaurignac, Guillaume, Leendertz, Fabian H, Vanlerberghe, Veerle, Pelloquin, Raphaël, Etard, Jean-François, Maman, David, Mbala, Placide K, Ayouba, Ahidjo, Peeters, Martine, Muyembe, Jean-Jacques T, Delaporte, Eric, Ahuka, Steve M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244674/
https://www.ncbi.nlm.nih.gov/pubmed/34089598
http://dx.doi.org/10.1093/cid/ciab515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244674/
https://www.ncbi.nlm.nih.gov/pubmed/34089598
http://dx.doi.org/10.1093/cid/ciab515

Ejemplares similares